Moolec Science (MLEC) Other Working Capital Changes (2023 - 2024)
Moolec Science (MLEC) reported Other Working Capital Changes of -$613951.0 for Q4 2024, down 2074.63% on a YoY basis from $31092.0 in Q1 2024, and down 8971.38% sequentially from -$6768.0 in Q3 2024.
Moolec Science (MLEC) Other Working Capital Changes (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Other Working Capital Changes data on file, last reported at -$613951.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Working Capital Changes fell 2074.63% year-over-year to -$613951.0; the trailing twelve-month figure through Dec 2024 stood at -$293316.0 (down 25.18% YoY), and the FY2024 full-year result was $367560.0, up 233.03% from the prior year.
- Other Working Capital Changes slipped to -$613951.0 in Q4 2024, from -$6768.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $321246.0 in Q4 2024 to a low of -$399316.0 in Q2 2024.
- A 3-year average of -$49678.8 and a median of -$407.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 2327.27% in 2023, while the deepest fall reached 5396.74% in 2023.
- Tracing MLEC's Other Working Capital Changes over 3 years: stood at -$1408.0 in 2022, then soared by 2308.24% to $31092.0 in 2023, then tumbled by 2074.63% to -$613951.0 in 2024.
- Business Quant data shows MLEC's Other Working Capital Changes at -$613951.0 in Q4 2024, -$6768.0 in Q3 2024, and $298957.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,334.77 Bn | 68,334.48 Bn | - |
| 2 | Nanobiotix | 1,887.92 Bn | 1,887.86 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.16 Bn | 470.37 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.97 Bn | 115.73 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.33 Bn | 60.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.61 Bn | 62.61 Bn | - |
| 8 | Argenx Se | 57.10 Bn | 51.92 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.39 Bn | 38.39 Bn | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 321,246.00 |
| Dec 31, 2024 | 321,246.00 |
| Dec 31, 2024 | 321,246.00 |
| Sep 30, 2024 | 258,492.00 |
| Sep 30, 2024 | 258,492.00 |
| Sep 30, 2024 | 258,492.00 |
| Jun 30, 2024 | -399,316.00 |
| Jun 30, 2024 | -399,316.00 |
| Jun 30, 2024 | -399,316.00 |
| Mar 31, 2024 | -218,814.00 |
| Mar 31, 2024 | -218,814.00 |
| Mar 31, 2024 | -218,814.00 |
| Dec 31, 2023 | 127,817.00 |
| Dec 31, 2023 | 127,817.00 |
| Dec 31, 2023 | 127,817.00 |
| Sep 30, 2023 | 198,467.00 |
| Sep 30, 2023 | 198,467.00 |
| Sep 30, 2023 | 198,467.00 |